• All
  • Manufacturing
  • Marketing
  • Biotech
  • Regulatory
  • Pharmaceutical
  • All

    Global threat gains steam as GlaxoSmithKline halts generic Zantac supply

    Life Science news you need to know. Fierce Pharma

    AstraZeneca, FibroGen's roxadustat heart data dispel safety doubts—or most of them

    Passing this around on e-mail today: Fierce Pharma

    Weill Family Foundation gifts $106M for public-private 'Neurohub'

    Share with your team: Fierce Biotech

    Promore Pharma is granted a patent for PXL01 in the US

    All the latest: Biospace

    AstraZeneca's Anifrolumab for Lupus Has Potential to Compete with GlaxoSmithKline's Benlysta

    So relevant: Biospace

    Sponsored Ad

    Featured

    Sponsored Ad

    Novartis' Zolgensma faces EU, Japan delays after regulators raise 'manufacturing questions'

    You heard it from SOURCE EXPLORER. Fierce Pharma

    Novartis' Cosentyx, Eli Lilly's Taltz cue new fight with spondyloarthritis data

    This is what’s on our minds: Fierce Pharma

    Kiadis dumps phase 3 drug, halves head count in pivot to NK cells

    Have you read this yet? Fierce Biotech

    FDA Slaps Second Clinical Hold on Solid Biosciences’ DMD Gene Therapy Due to ...

    Expert thoughts. Biospace

    Recent Financing Rounds in the Biopharma Industry

    Let us know what you think about this: Biospace

    SOURCE EXPLORER Updates

    New Commercial Models in the Pharma Industry

    Sponsored Ad

    Pharma Companies Killing It with Social Media

    The Future of Digital Health

    Shut the Font Up!

    The Future of Pharmaceutical Sales Reps

    View all Updates